Tags

Type your tag names separated by a space and hit enter

Development of medication-use indicators by the Joint Commission on Accreditation of Healthcare Organizations.
Am J Hosp Pharm. 1991 Sep; 48(9):1925-30.AJ

Abstract

The development of indicators for monitoring medication use is described. The Joint Commission on Accreditation of Healthcare Organizations is establishing a national database for use in measuring performance. Initially, indicators were developed for specialties or clinical departments and for disease entities or procedures; now, indicators for key functions that cross departmental and specialty lines, such as medication use, are under development. An interdisciplinary core group constructed a medication-use flow chart depicting prescribing, dispensing, administering, and monitoring patient response; systems management/control was recognized as a fifth component. Sixteen processes were identified for which indicators were developed. Proposed indicators are now being tested in a small number of hospitals. The indicator data will enable institutions to identify areas for improvement. Although the Joint Commission will not use indicator rates per se to determine accreditation, it will ask an institution to provide an interpretation of indicator data that differ markedly from previous data or data for comparable institutions and to review its strategy for analyzing the rates. Use of indicator data will enhance the accreditation process by allowing for ongoing monitoring of particular aspects of performance between onsite surveys.

Authors+Show Affiliations

Indicator Development, Joint Commission on Accreditation of Healthcare Organizations, Chicago, IL 60611.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

1928134

Citation

Nadzam, D M.. "Development of Medication-use Indicators By the Joint Commission On Accreditation of Healthcare Organizations." American Journal of Hospital Pharmacy, vol. 48, no. 9, 1991, pp. 1925-30.
Nadzam DM. Development of medication-use indicators by the Joint Commission on Accreditation of Healthcare Organizations. Am J Hosp Pharm. 1991;48(9):1925-30.
Nadzam, D. M. (1991). Development of medication-use indicators by the Joint Commission on Accreditation of Healthcare Organizations. American Journal of Hospital Pharmacy, 48(9), 1925-30.
Nadzam DM. Development of Medication-use Indicators By the Joint Commission On Accreditation of Healthcare Organizations. Am J Hosp Pharm. 1991;48(9):1925-30. PubMed PMID: 1928134.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Development of medication-use indicators by the Joint Commission on Accreditation of Healthcare Organizations. A1 - Nadzam,D M, PY - 1991/9/1/pubmed PY - 1991/9/1/medline PY - 1991/9/1/entrez SP - 1925 EP - 30 JF - American journal of hospital pharmacy JO - Am J Hosp Pharm VL - 48 IS - 9 N2 - The development of indicators for monitoring medication use is described. The Joint Commission on Accreditation of Healthcare Organizations is establishing a national database for use in measuring performance. Initially, indicators were developed for specialties or clinical departments and for disease entities or procedures; now, indicators for key functions that cross departmental and specialty lines, such as medication use, are under development. An interdisciplinary core group constructed a medication-use flow chart depicting prescribing, dispensing, administering, and monitoring patient response; systems management/control was recognized as a fifth component. Sixteen processes were identified for which indicators were developed. Proposed indicators are now being tested in a small number of hospitals. The indicator data will enable institutions to identify areas for improvement. Although the Joint Commission will not use indicator rates per se to determine accreditation, it will ask an institution to provide an interpretation of indicator data that differ markedly from previous data or data for comparable institutions and to review its strategy for analyzing the rates. Use of indicator data will enhance the accreditation process by allowing for ongoing monitoring of particular aspects of performance between onsite surveys. SN - 0002-9289 UR - https://www.unboundmedicine.com/medline/citation/1928134/Development_of_medication_use_indicators_by_the_Joint_Commission_on_Accreditation_of_Healthcare_Organizations_ DB - PRIME DP - Unbound Medicine ER -